XML 45 R35.htm IDEA: XBRL DOCUMENT v3.21.2
EMPLOYEE STOCK COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Share-based Compensation Expense
The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended
September 30,
Nine Months Ended
September 30,
($ in thousands)2021202020212020
Stock options$— $— $— $
Restricted stock awards and units1,106 1,346 3,988 4,388 
Total share-based compensation expense$1,106 $1,346 $3,988 $4,392 
Related tax benefits$326 $396 $1,175 $1,293 
Restricted Stock and Restricted Stock Units Activity
The following table presents unvested restricted stock awards and restricted stock units activity for the three and nine months ended September 30, 2021:
Three Months Ended
September 30, 2021
Nine Months Ended
September 30, 2021
Number of SharesWeighted Average Grant Date Fair Value Per ShareNumber of SharesWeighted
Average Grant
Date Fair Value
Per Share
Outstanding at beginning of period697,088 $17.13 848,302 $14.42 
Granted (1)
14,312 $17.47 283,642 $19.87 
Vested (2)
(11,809)$15.14 (367,089)$13.75 
Forfeited (3)
(38,724)$17.31 (103,988)$14.24 
Outstanding at end of period660,867 $17.16 660,867 $17.16 
(1)There were zero and 66,472 performance-based shares/units included in shares granted for the three and nine months ended September 30, 2021.
(2)There were zero and 77,327 performance-based shares/units included in vested shares for the three and nine months ended September 30, 2021.
(3)The number of forfeited shares includes aggregate performance-based shares/units of 8,643 and 48,803 for the three and nine months ended September 30, 2021.
Option Activity
The following table represents stock option activity for the three months ended September 30, 2021:
Three Months Ended September 30, 2021
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period14,904 $13.05 
Exercised— $— 
Outstanding at end of period14,904 $13.05 3.5 years$81 
Exercisable at end of period14,904 $13.05 3.5 years$81 

The following table represents stock option activity for the nine months ended September 30, 2021:
Nine Months Ended September 30, 2021
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contract TermAggregated Intrinsic Value
Outstanding at beginning of period55,069 $13.96 
Exercised(40,165)$14.30 
Outstanding at end of period14,904 $13.05 3.5 years$81 
Exercisable at end of period14,904 $13.05 3.5 years$81 
Summary of all Outstanding SARs The following table represents SARs activity and the weighted average exercise price per share as of and for the three and nine months ended September 30, 2021:
Three Months Ended
September 30, 2021
Nine Months Ended
September 30, 2021
($ in thousands except per share data)Number of SharesWeighted-Average Exercise Price Per ShareNumber of SharesWeighted-Average Exercise Price Per Share
Outstanding at beginning of period— $— 1,559,012 $11.60 
Exercised— $— (1,559,012)$11.60 
Outstanding at end of period $  $ 
Exercisable at end of period $  $